SELLAS Life Sciences Group Inc (NASDAQ:SLS)’s traded shares stood at 2.47 million during the last session, with the company’s beta value hitting 2.35. At the close of trading, the stock’s price was $1.62, to imply an increase of 4.52% or $0.07 in intraday trading. The SLS share’s 52-week high remains $1.84, putting it -13.58% down since that peak but still an impressive 52.47% since price per share fell to its 52-week low of $0.77. The company has a valuation of $153.17M, with an average of 1.98 million shares in intraday trading volume over the past 10 days and average of 1.52 million shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for SELLAS Life Sciences Group Inc (SLS), translating to a mean rating of 1.00. Of 2 analyst(s) looking at the stock, 0 analyst(s) give SLS a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 2 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -0.11.
SELLAS Life Sciences Group Inc (NASDAQ:SLS) trade information
After registering a 4.52% upside in the last session, SELLAS Life Sciences Group Inc (SLS) has traded red over the past five days. The 5-day price performance for the stock is 20.90%, and 48.62% over 30 days. With these gigs, the year-to-date price performance is 55.77%. Short interest in SELLAS Life Sciences Group Inc (NASDAQ:SLS) saw shorts transact 7.77 million shares and set a 7.59 days time to cover.
The extremes give us $2.4 and $3.2 for target low and target high price respectively. As such, SLS has been trading -97.53% off suggested target high and -48.15% from its likely low.
An assessment of the company’s 5-year growth patterns shows that annual earnings grew an estimated 45.94% for the past 5-year period. While 2025 is set for a 15.00% return in earnings, projections for the next 5 years are at 42.51% annually.
SLS Dividends
SELLAS Life Sciences Group Inc has its next earnings report out on 2025-Mar-19. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
SELLAS Life Sciences Group Inc (NASDAQ:SLS)’s Major holders
SELLAS Life Sciences Group Inc insiders hold 0.30% of total outstanding shares, with institutional holders owning 6.55% of the shares at 6.57% float percentage. In total, 6.55% institutions holds shares in the company, led by VANGUARD GROUP INC. As of 2024-06-30, the company held over 1.79 million shares (or 3.9862% of shares), all amounting to roughly $2.13 million.
The next major institution holding the largest number of shares is SUSQUEHANNA INTERNATIONAL GROUP, LLP with 1.64 million shares, or about 3.6594% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $1.95 million.
